Laboratorios Farmaceuticos ROVI Net Asset Quality Index
Laboratorios Farmaceuticos ROVI net asset quality index. Laboratorios Farmaceuticos ROVI (ROVI) has a Net Asset Quality Index of 68.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €922.07 Million minus total liabilities of €289.27 Million yields net assets of €632.80 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Laboratorios Farmaceuticos ROVI (ROVI) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Laboratorios Farmaceuticos ROVI (2003–2024)
Net asset quality index of Laboratorios Farmaceuticos ROVI from 2003 to 2024. This chart shows how Laboratorios Farmaceuticos ROVI's Net Asset Quality Index has evolved across 22 annual periods from 2003 to 2024. As of September 2025, the index stands at 68.6%, representing net assets of €632.80 Million against total assets of €922.07 Million EUR. See ROVI book value for net asset value and shareholders' equity analysis.
Laboratorios Farmaceuticos ROVI Net Asset Quality Index by Year (2003–2024)
Laboratorios Farmaceuticos ROVI net asset quality index by year from 2003 to 2024. The table below presents the year-by-year Net Asset Quality Index for Laboratorios Farmaceuticos ROVI from 2003 to 2024, covering 22 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ROVI market cap overview.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 69.9% | €581.54 Million | €832.02 Million | €250.48 Million | ▲ +1.9 pp |
| 2023 | 67.9% | €543.49 Million | €799.88 Million | €256.39 Million | ▲ +8.6 pp |
| 2022 | 59.3% | €521.38 Million | €878.70 Million | €357.32 Million | ▼ -4.9 pp |
| 2021 | 64.3% | €470.98 Million | €732.68 Million | €261.70 Million | ▼ -0.8 pp |
| 2020 | 65.1% | €373.70 Million | €574.44 Million | €200.74 Million | ▲ +2.0 pp |
| 2019 | 63.1% | €322.39 Million | €511.21 Million | €188.82 Million | ▼ -8.3 pp |
| 2018 | 71.4% | €287.47 Million | €402.70 Million | €115.23 Million | ▲ +7.1 pp |
| 2017 | 64.2% | €191.69 Million | €298.38 Million | €106.69 Million | ▲ +0.5 pp |
| 2016 | 63.7% | €183.41 Million | €287.85 Million | €104.44 Million | ▲ +1.3 pp |
| 2015 | 62.5% | €164.78 Million | €263.85 Million | €99.06 Million | ▲ +1.8 pp |
| 2014 | 60.6% | €158.47 Million | €261.32 Million | €102.85 Million | ▼ -0.6 pp |
| 2013 | 61.2% | €144.46 Million | €235.92 Million | €91.46 Million | ▲ +4.4 pp |
| 2012 | 56.9% | €126.45 Million | €222.36 Million | €95.92 Million | ▲ +6.9 pp |
| 2011 | 50.0% | €113.98 Million | €228.07 Million | €114.09 Million | ▲ +1.1 pp |
| 2010 | 48.9% | €104.13 Million | €212.89 Million | €108.75 Million | ▲ +5.8 pp |
| 2009 | 43.1% | €71.50 Million | €165.91 Million | €94.42 Million | ▲ +2.9 pp |
| 2008 | 40.2% | €48.44 Million | €120.55 Million | €72.11 Million | ▼ -6.1 pp |
| 2007 | 46.3% | €51.92 Million | €112.16 Million | €60.23 Million | ▲ +12.4 pp |
| 2006 | 33.9% | €25.81 Million | €76.04 Million | €50.23 Million | ▼ -25.0 pp |
| 2005 | 58.9% | €4.80 Trillion | €8.15 Trillion | €3.35 Trillion | ▲ +58.9 pp |
| 2004 | 0.0% | €2.92 Million | €7.88 Billion | €7.88 Billion | ▼ -36.6 pp |
| 2003 | 36.6% | €17.80 Million | €48.60 Million | €30.80 Million | — |